Progenity Inc PROG:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:37 PM EST
5.47quote price arrow down-0.10 (-1.80%)
Volume
5,003
Close
5.57quote price arrow down-0.30 (-5.11%)
Volume
486,712
52 week range
3.08 - 15.92

...

Loading . . .

KEY STATS

  • Open5.89
  • Day High5.91
  • Day Low5.27
  • Prev Close5.87
  • 52 Week High15.92
  • 52 Week High Date06/19/20
  • 52 Week Low3.08
  • 52 Week Low Date12/03/20
  • Market Cap310.75M
  • Shares Out55.79M
  • 10 Day Average Volume0.41M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-8.76
  • P/E (TTM)-0.64
  • Fwd P/E (NTM)-1.73
  • EBITDA (MRQ)-164.141M
  • ROE (MRQ)-
  • Revenue (MRQ)113.31M
  • Gross Margin (MRQ)9.41%
  • Net Margin (MRQ)-124.59%
  • Debt To Equity (MRQ)-121.27%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Progenity Inc News

There is no recent news for this security.

Latest PROG News From Our Partners

QUOTE FINDER

Profile

MORE
Progenity, Inc. is a biotechnology company. The Company is engaged in developing and commercializing molecular testing products and precision medicine. It applies multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics, to its molecular testing products and to the development of a suite of investigational ingestible devices and drug/device combinations designed to provide precise diagnostic sampling and drug delivery solutions. It offers integrated...
Harry Stylli Ph.D.
Chairman
Damon Silvestry
Chief Operating Officer
Eric d'Esparbes
Chief Financial Officer
Troy Seelye
Chief Information Officer
Clarke Neumann J.D.
General Counsel
Address
4330 La Jolla Village Dr Ste 200
San Diego, CA
92122
United States